BCDA•benzinga•
BioCardia Doses First Patient In Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial Of Cell Therapy For Treatment Of Heart Failure
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 1, 2025 by benzinga